alphaveGUFICBIO₹427.80

Gufic Biosciences Limited

₹ CrorePeersRPGLIFE UNICHEMLAB GUJTHEM ORCHPHARMA SMSPHARMA INDSWFTLAB FDC IOLCPMcap ₹4,290 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	153.3	499.6	484.9	484.9
+ Capital Work-in-Progress	307.1	21.8	22.1	22.1
+ Other Intangibles	5.6	6.3	6.2	6.2
+ Non-current Investments	1.8	1.8	1.8	1.8
+ Long-term Loans	0.4	0.2	0.5	0.5
+ Other Non-current Financial Assets	8.9	9.7	24.8	24.8
Non-current Financial Assets	11.1	11.7	27.1	27.1
+ Other Non-current Assets	15.0	5.3	—	—
Total Non-current Assets	492.1	544.8	540.3	540.3
Current Assets
+ Inventories	200.5	216.9	324.5	324.5
+ Trade Receivables	329.9	314.6	297.4	297.4
+ Cash & Cash Equivalents	1.1	15.7	62.2	62.2
+ Other Bank Balances	12.3	13.3	14.0	14.0
+ Short-term Loans	0.4	0.3	0.7	0.7
+ Other Current Financial Assets	0.0	62.1	—	—
Current Financial Assets	343.8	406.1	374.3	374.3
+ Other Current Assets	56.2	0.0	101.8	101.8
Total Current Assets	600.5	624.5	802.1	802.1
Total Assets	1,092.5	1,169.4	1,342.4	1,342.4
Equity
+ Equity Share Capital	10.0	10.0	10.0	10.0
+ Other Equity / Reserves	522.5	591.0	654.9	654.9
Equity — Owners of Parent	532.6	601.1	664.9	664.9
+ Minority Interest	—	0.0	0.0	0.0
Total Equity	532.6	601.1	665.0	665.0
Liabilities
+ Borrowings — Non-current	154.0	130.5	105.0	105.0
+ Other Non-current Financial Liab	16.5	25.0	19.9	19.9
Non-current Financial Liabilities	170.5	155.5	125.0	125.0
+ Provisions — Non-current	15.4	17.5	18.0	18.0
+ Deferred Tax Liabilities	2.1	7.8	16.6	16.6
Non-current Liabilities	187.9	180.7	159.5	159.5
+ Borrowings — Current	163.1	179.9	280.1	280.1
+ Trade Payables	166.3	158.7	199.0	199.0
+ Other Current Financial Liab	18.1	21.4	21.2	21.2
Current Financial Liabilities	347.4	360.0	500.4	500.4
+ Provisions — Current	4.7	4.4	4.5	4.5
+ Current Tax Liabilities	2.5	0.0	1.9	1.9
+ Other Current Liabilities	17.4	23.1	11.0	11.0
Current Liabilities	372.0	387.6	517.8	517.8
Total Liabilities	560.0	568.3	677.4	677.4
Total Equity & Liabilities	1,092.5	1,169.4	1,342.4	1,342.4
Assets — additional as-filed lines
+ Current Tax Assets	0.0	1.6	1.6	1.6
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	2.2	0.5	0.5
+ Dues to Other Creditors — Current	—	156.5	198.5	198.5

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.